Table 3. Correlation of Notch receptor mRNA high expression with PFS in clinical stages of ovarian cancer patients.
| Notch receptors | Clinical stages | Cases | HR 95% CI | P value |
|---|---|---|---|---|
| Notch 1 | I + II III IV |
126 846 143 |
0.99 (0.55–1.79) 0.98 (0.83–1.15) 1.05 (0.7–1.57) |
0.97 0.80 0.81 |
| Notch 2 | I + II III IV |
126 846 143 |
0.79 (0.43–1.43) 1.07 (0.91–1.26) 1.48 (0.98–2.22) |
0.43 0.39 0.059 |
| Notch 3 | I + II III IV |
126 846 143 |
1.09 (0.6–1.98) 0.99 (0.84–1.16) 1.01 (0.67–1.5) |
0.77 0.86 0.98 |
| Notch 4 | I + II III IV |
126 846 143 |
1.12 (0.61–2.06) 1.09 (0.93–1.28) 1.37 (0.92–2.06) |
0.71 0.30 0.12 |
Note: four-tier grading scheme for clinical stages.